Dr. Böcking served as the Head of Cytopathology at the University Hospital of Dusseldorf from 1994 to 2009. He also held the position of President of the European Society for Analytical Cellular Pathology from 1995 to 1998. After moving to Berlin 3 years ago, Dr. Böcking established a cooperation with the Department of Digital Pathology at the Charité University Hospital, where he continues to remain a consultant pathologist.
Dr. Böcking has dedicated his career to developing instruments used to detect cancers. With over 280 scientific publications, 110 of these publications are focused on DNA-Cytometry used within cancer research.
Dr. Alfred Böcking has partnered with Motic for over fifteen years, co-developing the software of all MotiCyte systems that is still used in newer models today. This software utilizes artificial intelligence to automatically detect cancer cells of different origins, the first of its kind to do so worldwide. Recently, Dr. Alfred Bocking’s expertise has been instrumental in the development of the software implemented within the EasyScan-AI, coming to market in late 2020. Today, Dr. Bocking remains a consultant to the MMDS telepathology platform, as well as overseeing software developments on MotiCyte systems.